High-intensity focused ultrasound principles, current uses, and potential for the future

Ultrasound Quarterly

Volumn 22, Issue 4, 2006, Pages 263-272

  Leslie, Thomas A ^a   Kennedy, James E ^b  

^a CHURCHILL HOSPITAL   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Bone cancer; Focused ultrasound; HIFU; Kidney cancer; Liver cancer; Pancreatic cancer; Prostate cancer

Indexed keywords

ABDOMINAL TUMOR; BONE TUMOR; BREAST CANCER; CHEMOEMBOLIZATION; CLINICAL TRIAL; DIAGNOSTIC IMAGING; HIGH INTENSITY FOCUSED ULTRASOUND; HUMAN; IMAGING SYSTEM; IMPOTENCE; KIDNEY TUMOR; LIVER CANCER; LIVER CELL CARCINOMA; MEDICAL INSTRUMENTATION; MEDICAL PRACTICE; MORBIDITY; NONHUMAN; PANCREAS CANCER; PRIORITY JOURNAL; PROSTATE CANCER; RADIATION INJURY; RECTUM INJURY; REVIEW; SOFT TISSUE TUMOR; TUMOR VOLUME; URINE INCONTINENCE; UTERUS MYOMA;

HUMANS; NEOPLASMS; ULTRASONIC THERAPY;

EID: 33845474305     PISSN: 08948771     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.ruq.0000237259.25885.72     Document Type: Review

References (122)

1. Wood RW, Loomis AL. The physical and biological effects of high-frequency sound waves of great intensity. London Edinburgh Dublin Phils Mag J Sci. 1927;4:417-436.
2. Fry WJ, Mosberg WH, Barnard JW, et al. Production of focal destructive lesions in the central nervous system with ultrasound. J Neurosurg. 1954;11:471-478.
3. Fry WJ, Barnard JW, Fry FJ, et al. Ultrasonic lesions in the mammalian central nervous system. Science. 1955;122:517-518.
4. Lele PP. Production of deep focal lesions by focused ultrasound - current status. Ultrasonics. April 1967:105.
5. Kennedy JE, ter Haar GR, Cranston D. High intensity focused ultrasound: surgery of the future? Br J Radiol. 2003;76:590-599.
6. ter Haar G, Clarke RL, Vaughan MG, et al. Trackless surgery using focused ultrasound: technique and case report. Minim Invasive Ther. 1991;1:13-19.
7. Hill CR, ter Haar GR. Review article: high intensity focused ultrasound: potential for cancer treatment. Br J Radiol. 1995;68:1206-1303.
8. Vaughan MG, ter Haar GR, Hill CR, et al. Minimally invasive cancer surgery using focused ultrasound: a preclinical, normal tissue study. Br J Radiol. 1994;67:267-274.
9. Clement GT. Perspectives in clinical uses of high-intensity focused ultrasound. Ultrasonics. 2004;42:1087-1093.
10. Mason TJ. A sound investment. Chem Indust. 1998:878-882.
11. Hynynen K. The threshold for thermally significant cavitation in dog's thigh muscle in vivo. Ultrasound Med Biol. 1991;17:157-169.
12. Tran BC, Seo J, Hall TL, et al. Microbubble-enhanced cavitation for noninvasive ultrasound surgery. IEEE Trans Ultrason Ferroelectr Freq Control. 2003;50:1296-1304.
13. McDannold N, Vykhodtseva N, Hynynen K. Targeted disruption of the blood-brain barrier with focused ultrasound: association with cavitation activity. Phys Med Biol. 2006;51:793-807.
14. Brujan EA, Ikeda T, Matsumoto Y. Jet formation and shock wave emission during collapse of ultrasound-induced cavitation bubbles and their role in the therapeutic applications of high-intensity focused ultrasound. Phys Med Biol. 2005;50:4797-4809.
15. Datta S, Coussios CC, McAdory LE, et al. Correlation of cavitation with ultrasound enhancement of thrombolysis. Ultrasound Med Biol. 2006;32:1257-1267.
16. Coussios CC, Collin JRT, Muckle AP. Non-invasive monitoring and control of inertial cavitation dynamics during HIFU exposure in vitro. Proceedings of the 6th International Symposium Therapeutic Ultrasound. 2006. In press.
17. Parsons JE, Cain CA, Abrams GD, et al. Pulsed cavitational ultrasound therapy for controlled tissue homogenization. Ultrasound Med Biol. 2006;32:115-129.
18. Wu F, Chen WZ, Bai J, et al. Pathological changes in human malignant carcinoma treated with high-intensity focused ultrasound. Ultrasound Med Biol. 2001;27:1099-1106.
19. Madersbacher S, Kratzik C, Susani M, et al. Tissue ablation in benign prostatic hyperplasia with high intensity focused ultrasound. J Urol. 1994;152:1956-1960.
20. Hynynen K, Pomeroy O, Smith DN, et al. MR imaging-guided focused ultrasound surgery of fibroadenomas in the breast: a feasibility study. Radiology. 2001;219:176-185.
21. Illing RO, Leslie TA, Kennedy JE, et al. Visually directed HIFU for organ confined prostate cancer - a proposed standard for the conduct of therapy. BJU Int. 2006. In press.
22. Wu F, Wang Z, Wang Z, et al. Changes in ultrasonic image of tissue damaged by high intensity ultrasound in vivo. J Acoust Soc Am. 1998;103:2869.
23. Hynynen K, Darkazanli A, Unger E, et al. MRI-guided noninvasive ultrasound. Med Phys. 1993;20:107-115.
24. Visioli AG, Rivens IH, ter Haar GR, et al. Preliminary results of a phase I dose escalation clinical trial using focused ultrasound in the treatment of localised tumours. Eur J Ultrasound. 1999;9:11-18.
25. Vimeux FC, De Zwart JA, Palussiere J, et al. Real-time control of focused ultrasound heating based on rapid MR thermometry. Invest Radiol. 1999;34:190-193.
26. Thuroff S, Chaussy C, Vallancien G, et al. High-intensity focused ultrasound and localized prostate cancer: efficacy results from the European multicentric study. J Endourol. 2003;17:673-677.
27. Uchida T, Sanghvi NT, Gardner TA, et al. Transrectal high-intensity focused ultrasound for treatment of patients with stage T1b-2n0m0 localized prostate cancer: a preliminary report. Urology. 2002;59:394-398.
28. Vallancien G, Harouni M, Guillonneau B, et al. Ablation of superficial bladder tumors with focused extracorporeal pyrotherapy. Urology. 1996;47:204-207.
29. Kohrmann KU, Michel MS, Gaa J, et al. High intensity focused ultrasound as noninvasive therapy for multilocal renal cell carcinoma: case study and review of the literature. J Urol. 2002;167:2397-2403.
30. Gianfelice D, Khiat A, Amara M, et al. MR imaging-guided focused US ablation of breast cancer: histopathologic assessment of effectiveness - initial experience. Radiology. 2003;227:849-855.
31. Wu F, Wang ZB, Chen WZ, et al. Extracorporeal focused ultrasound surgery for treatment of human solid carcinomas: early Chinese clinical experience. Ultrasound Med Biol. 2004;30:245-260.
32. Wu F, Chen W, Bai J. Effect of high-intensity focused ultrasound on patients with hepatocellular cancer - preliminary report. Chinese J Ultrason. 1999;8:213-216.
33. Madersbacher S, Kratzik C, Szabo N, et al. Tissue ablation in benign prostatic hyperplasia with high-intensity focused ultrasound. Eur Urol. 1993;23(suppl 1):39-43.
34. Chaussy C, Thuroff S. High-intensity focused ultrasound in prostate cancer: results after 3 years. Mol Urol. 2000;4:179-182.
35. ter Harr G, Rivens I, Chen L, et al. High intensity focused ultrasound for the treatment of rat tumours. Phys Med Biol. 1991;36:1495-1501.
36. Chapelon JY, Margonari J, Theillere Y, et al. Effects of high-energy focused ultrasound on kidney tissue in the rat and the dog. Eur Urol. 1992;22:147-152.
37. Oosterhof GON, Cornel EB, Smits GAHJ, et al. Influence of high-intensity focused ultrasound on the development of metastases. Eur Urol. 1997;32:91-95.
38. Stewart EA, Gedroyc WM, Tempany CM, et al. Focused ultrasound treatment of uterine fibroid tumors: safety and feasibility of a noninvasive thermoablative technique. Am J Obstet Gynecol. 2003;189:48-54.
39. Kennedy JE, Wu F, ter Haar GR, et al. High-intensity focused ultrasound for the treatment of liver tumours. Ultrasonics. 2004;42:931.
40. Kennedy JE. High-intensity focused ultrasound in the treatment of solid tumours. Nat Rev Cancer. 2005;5:321-327.
41. Leon-Villapalos J, Kaniorou-Larai M, Dziewulski P. Full thickness abdominal burn following magnetic resonance guided focused ultrasound therapy. Burns. 2005;31:1054-1055.
42. Taylor KJ, Connolly CC. Differing hepatic lesions caused by the same dose of ultrasound. J Pathol. 1969;98:291-293.
43. Linke CA, Carstensen EL, Frizzell LA, et al. Localized tissue destruction by high-intensity focused ultrasound. Arch Surg. 1973;107:887-891.
44. Frizzell LA. Threshold dosages for damage to mammalian liver by high intensity focused ultrasound. IEEE Trans Ultrason Ferroelectr Freq Control. 1988;35:578.
45. Bush NL, Rivens I, ter Haar GR, et al. Acoustic properties of lesions generated with an ultrasound therapy system. Ultrasound Med Biol. 1993;19:789-801.
46. Arefiev A, Prat F, Chapelon JY, et al. Ultrasound-induced tissue ablation: studies on isolated, perfused porcine liver. Ultrasound Med Biol. 1998;24:1033-1043.
47. Wang ZB, Wu F, Wang ZL, et al. Targeted damage effects of high intensity focused ultrasound (HIFU) on liver tissues of Guizhou Province miniswine. Ultrason Sonochem. 1997;4:181-182.
48. Bai J, Wu F, Wang Z-B, et al. Localised lesion to normal miniswine liver with high-intensity focused ultrasound and dose-effect relation. Chinese J Ultrason. 1999;8:247-250.
49. Ruan X, Du Y, Kong F. Pathological regression following localised ablation of liver tissue of 28 miniswine with high-intensity focused ultrasound. Chin J Exp Surg. 1999;16:263-264.
50. Wu, F, Wang, Z, Chen, W, et al. Extracorporeal high-intensity focused ultrasound for treatment of solid carcinomas: four-year Chinese clinical experience. In: Andrew M, Crum L, Vaezy S, eds. Proceedings of the 2nd International Symposium Therapeutic Ultrasound. Seattle, WA: University of Washington; 2003:34-43.
51. Wu F, Wang ZB, Chen WZ, et al. Advanced hepatocellular carcinoma: treatment with high-intensity focused ultrasound ablation combined with transcatheter arterial embolization. Radiology. 2005;235:659-667.
52. Illing RO, Kennedy JE, Wu F, et al. The safety and feasibility of extracorporeal high-intensity focused ultrasound (HIFU) for the treatment of liver and kidney tumours in a Western population. Br J Cancer. 2005;93:890-895.
53. Adams JB, Moore RG, Anderson JH, et al. High-intensity focused ultrasound ablation of rabbit kidney tumors. J Endourol. 1996;10:71-75.
54. Watkin NA, Morris SB, Rivens IH, et al. High-intensity focused ultrasound ablation of the kidney in a large animal model. J Endourol. 1997;11:191-196.
55. Roberts WW, Hall TL, Ives K, et al. Pulsed cavitational ultrasound: a noninvasive technology for controlled tissue ablation (histotripsy) in the rabbit kidney. J Urol. 2006;175:734-738.
56. Vallancien G, Chartier-Kastler E, Harouni M, et al. Focused extracorporeal pyrotherapy: experimental study and feasibility in man. Semin Urol. 1993;11:7-9.
57. Marberger M, Schatzl, G, Cranston D, et al. Extracorporeal ablation of renal tumors with high intensity focused ultrasound. BJU Int. 2005;95(suppl 2):52-55.
58. Wu F, Wang ZB, Chen WZ, et al. Preliminary experience using high intensity focused ultrasound for the treatment of patients with advanced stage renal malignancy. J Urol. 2003;170:2237-2240.
59. Hacker A, Michel MS, Marlinghaus E, et al. Extracorporeally induced ablation of renal tissue by high-intensity focused ultrasound. BJU Int. 2006;97:779-785.
60. Fry FJ, Barger JE. Acoustical properties of the human skull. J Acoust Soc Am. 1978;63:1576-1590.
61. Foldes K, Hynynen K, Shortkroff S, et al. Magnetic resonance imaging-guided focused ultrasound synovectomy. Scand J Rheumatol. 1999;28:233-237.
62. Smith NB, Temkin JM, Shapiro F, et al. Thermal effects of focused ultrasound energy on bone tissue. Ultrasound Med Biol. 2001;27:1427-1433.
63. Chen WZ, Wu F, Zhu H, et al. Preliminary study on high intensity focused ultrasonic treatment of osteosarcoma. Chin J Clin Oncol. 2001;28:489-491.
64. Chen W, Wang Z, Wu F, et al. High intensity focused ultrasound alone for malignant solid tumors. Zhonghua Zhong Liu Za Zhi. 2002;24:278-281.
65. Wei W, Wenzhi C, Zhibiao W, et al. Follow-up of high-intensity focused ultrasound treatment of primary malignant bone tumours: a multicenter report. In: Proceedings of the 4th International Symposium Therapeutic Ultrasound; 2005:65.
66. Chen W, Wang Z, Wu F, et al. High intensity focused ultrasound in the treatment of primary malignant bone tumor. Zhonghua Zhong Liu Za Zhi. 2002;24:612-615.
67. Wu F, Wang ZB, Chen WZ, et al. Noninvasive ablation of high intensity focused ultrasound for the treatment of patients with primary bone malignancy. J Bone Joint Surg Br Orthop Proc. 2005;87-B:4.
68. Chen W, Zhou K. High-intensity focused ultrasound ablation: a new strategy to manage primary bone tumours. Curr Opin Orthop. 2005;16:494-500.
69. Wu F, Wang ZB, Zhu H, et al. Feasibility of US-guided high-intensity focused ultrasound treatment in patients with advanced pancreatic cancer: initial experience. Radiology. 2005;236:1034-1040.
70. Gianfelice D, Khiat A, Boulanger Y, et al. Feasibility of magnetic resonance imaging-guided focused ultrasound surgery as an adjunct to tamoxifen therapy in high-risk surgical patients with breast carcinoma. J Vasc Interv Radiol. 2003;14:1275-1282.
71. Wu F. Extracorporeal high intensity focused ultrasound in the treatment of patients with solid malignancy. Minim Invasive Ther Allied Technol. 2006;15:26-35.
72. Huber PE, Jenne JW, Rastert R, et al. A new noninvasive approach in breast cancer therapy using magnetic resonance imaging-guided focused ultrasound surgery. Cancer Res. 2001;61:8441-8447.
73. Zippel DB, Papa MZ. The use of MR imaging guided focused ultrasound in breast cancer patients; a preliminary phase one study and review. Breast Cancer. 2005;12:32-38.
74. Furusawa H, Namba K, Thomsen S, et al. Magnetic resonance-guided focused ultrasound surgery of breast cancer: reliability and effectiveness. J Am Coll Surg. 2006;203:54-63.
75. Wu F, Wang ZB, Cao YD, et al. Changes in biologic characteristics of breast cancer treated with high-intensity focused ultrasound. Ultrasound Med Biol. 2003;29:1487-1492.
76. Wu F, Wang ZB, Cao YD, et al. A randomised clinical trial of high-intensity focused ultrasound ablation for the treatment of patients with localised breast cancer. Br J Cancer. 2003;89:2227-2233.
77. Tempany CM, Stewart EA, McDannold N, et al. MR imaging-guided focused ultrasound surgery of uterine leiomyomas: a feasibility study. Radiology. 2003;226:897-905.
78. Hindley J, Gedroyc WM, Regan L, et al. MRI guidance of focused ultrasound therapy of uterine fibroids: early results. AJR Am J Roentgenol. 2004;183:1713-1719.
79. Stewart EA, Rabinovici J, Tempany CM, et al. Clinical outcomes of focused ultrasound surgery for the treatment of uterine fibroids. Fertil Steril. 2006;85:22-29.
80. Susani M, Madersbacher S, Kratzik C, et al. Morphology of tissue destruction induced by focused ultrasound. Eur Urol. 1993;23(suppl 1):34-38.
81. Foster RS, Bihrle R, Sanghvi NT, et al. High-intensity focused ultrasound in the treatment of prostatic disease. Eur Urol. 1993;23(suppl 1):29-33.
82. Gelet A, Chapelon JY, Margonari J, et al. High-intensity focused ultrasound experimentation on human benign prostatic hypertrophy. Eur Urol. 1993;23(suppl 1):44-47.
83. Visioli AG, Rivens IH, ter Haar GR, et al. Preliminary results of a phase I dose escalation clinical trial using focused ultrasound in the treatment of localised tumours. Eur J Ultrasound. 1999;9:11-18.
84. Vallancien G, Chartier-Kastler E, Bataille N, et al. Focused extracorporeal pyrotherapy. Eur Urol. 1993;23:48-52.
85. Kohrmann KU, Michel MS, Fruhauf J, et al. High intensity focused ultrasound for non-invasive tissue ablation in the kidney, prostate and uterus. J Urol. 2000;163:156.
86. Bihrle R, Foster RS, Sanghvi NT, et al. High intensity focused ultrasound for the treatment of benign prostatic hyperplasia: early United States clinical experience. J Urol. 1994;151:1271-1275.
87. Ebert T, Miller S, Schmitz-Drager B, et al. High-intensity focused ultrasound in patients with benign prostatic hyperplasia. J Urol. 1994;151:399A.
88. Nakamura K, Baba S, Fukazawa R, et al. Treatment of benign prostatic hyperplasia with high intensity focused ultrasound: an initial clinical trial in Japan with magnetic resonance imaging of the treated area. Int J Urol. 1995;2:176-180.
89. Uchida T, Yokoyama E, Iwamura M, et al. High intensity focused ultrasound for benign prostatic hyperplasia. Int J Urol. 1995;2:181-185.
90. Madersbacher S, Klingler CH, Schatzl G, et al. The urodynamic impact of transrectal high-intensity focused ultrasound on bladder outflow obstruction. Eur Urol. 1996;30:437-445.
91. Sanghvi NT, Fry FJ, Bihrle R, et al. Non-invasive surgery of prostate tissue by high-intensity focused ultrasound. IEEE Trans Ultrason Ferroelectr Freq Control. 1996;43:1099-1110.
92. Sullivan LD, McLoughlin MG, Goldenberg LG, et al. Early experience with high-intensity focused ultrasound for the treatment of benign prostatic hypertrophy. Br J Urol. 1997;79:172-176.
93. Nakamura K, Baba S, Saito S, et al. High-intensity focused ultrasound energy for benign prostatic hyperplasia: clinical response at 6 months to treatment using Sonablate 200. J Endourol. 1997;11:197-201.
94. Uchida T, Muramoto M, Kyunou H, et al. Clinical outcome of high-intensity focused ultrasound for treating benign prostatic hyperplasia: preliminary report. Urology. 1998;52:66-71.
95. Nakamura K, Baba S, Saito S, et al. A long-term response following high-intensity focused ultrasound for prostatic hyperplasia. J Urol. 1996;155(5 suppl):405.
96. Mulligan ED, Lynch TH, Mulvin D, et al. High-intensity focused ultrasound in the treatment of benign prostatic hyperplasia. Br J Urol. 1997;79:177-180.
97. Bihrle R, Foster RS, Tanagho E, et al. Two-year follow up results of US and Canadian multicentre trials using high-intensity focused ultrasound ablation for treatment of benign prostatic hyperplasia. J Urol. 1998;159(5 suppl):302.
98. Madersbacher S, Schatzl G, Djavan B, et al. Long-term outcome of transrectal high-intensity focused ultrasound therapy for benign prostatic hyperplasia. Eur Urol. 2000;37:687-694.
99. Schatzl G, Madersbacher S, Djavan B, et al. Two-year results of transurethral resection of the prostate versus four 'less invasive' treatment options. Eur Urol. 2000;37:695-701.
100. Marberger M, Susani M, Madersbacher S. Effects of high-intensity focused ultrasound on human prostate cancer. J Urol. 1994;151:436.
101. Madersbacher S, Pedevilla M, Vingers L, et al. Effect of high-intensity focused ultrasound on human prostate cancer in vivo. Cancer Res. 1995;55:3346-33351.
102. Gelet A, Chapelon JY, Bouvier R, et al. Treatment of prostate cancer with transrectal focused ultrasound: early clinical experience. Eur Urol. 1996;29:174-183.
103. Thuroff S, Chaussy C. High-intensity focused ultrasound against localised prostate cancer. An additive tool before hormone ablation? Paper presented at: EAU Conference; 1998; Barcelona.
104. Uchida T, Ohkusa H, Nagata Y, et al. Treatment of localized prostate cancer using high-intensity focused ultrasound. BJU Int. 2006;97:56-61.
105. Blana A, Walter B, Rogenhofer S, et al. High-intensity focused ultrasound for the treatment of localized prostate cancer: 5-year experience. Urology. 2004;63:297-300.
106. Gelet A, Chapelon JY, Poissonnier L, et al. Local recurrence of prostate cancer after external beam radiotherapy: early experience of salvage therapy using high-intensity focused ultrasonography. Urology. 2004;63:625-629.
107. Cox JD, Gallagher MJ, Hammond EH, et al. Consensus statements on radiation therapy of prostate cancer: guidelines for prostate re-biopsy after radiation and for radiation therapy with rising prostate-specific antigen levels after radical prostatectomy. American Society for Therapeutic Radiology and Oncology Consensus Panel. J Clin Oncol. 1999;17:1155.
108. Hynynen K, McDannold N. MRI guided and monitored focused ultrasound thermal ablation methods: a review of progress. Int J Hyperthermia. 2004;20:725-737.
109. McDannold N, Tempany CM, Fennessy FM, et al. Uterine leiomyomas: MR imaging-based thermometry and thermal dosimetry during focused ultrasound thermal ablation. Radiology. 2006;240:263-272.
110. Lafon C, Zderic V, Noble ML, et al. Gel phantom for use in high-intensity focused ultrasound dosimetry. Ultrasound Med Biol. 2005;31:1383-1389.
111. Gray R, Leslie T, Civale J, et al. A comparison of real-time feedback and tissue response to ultrasound-guided high intensity focused ultrasound (HIFU) ablation using scanned track exposure regimes. Proceedings of the 6th International Symposium Therapeutic Ultrasound. 2006. In press.
112. Righetti R, Kallel F, Stafford RJ, et al. Elastographic characterization of HIFU-induced lesions in canine livers. Ultrasound Med Biol. 1999;25:1099-1113.
113. Wu T, Felmlee JP, Greenleaf JF, et al. Assessment of thermal tissue ablation with MR elastography. Magn Reson Med. 2001;45:80-87.
114. Wu F, Wang ZB, Lu P, et al. Activated anti-tumor immunity in cancer patients after high intensity focused ultrasound ablation. Ultrasound Med Biol. 2004;30:1217-1222.
115. den Brok MH, Sutmuller RP, van der Voort R, et al. In situ tumor ablation creates an antigen source for the generation of antitumor immunity. Cancer Res. 2004;64:4024-4029.
116. Sun J, Hynynen K. The potential of transskull ultrasound therapy and surgery using the maximum available skull surface area. J Acoust Soc Am. 1999;105:2519-2527.
117. Clement GT, White J, Hynynen K. Investigation of a large-area phased array for focused ultrasound surgery through the skull. Phys Med Biol. 2000;42:1071-1083.
118. Pernot M, Aubry JF, Tanter M, et al. High power transcranial beam steering for ultrasonic brain therapy. Phys Med Biol. 2003;48:2577-2589.
119. McDannold N, Moss M, Killiany R, et al. MRI-guided focused ultrasound surgery in the brain: Tests in a primate model. Magn Reson Med. 2003;49:1188-1191.
120. Esnault O, Franc B, Monteil JP, et al. High-intensity focused ultrasound for localized thyroid-tissue ablation: preliminary experimental animal study. Thyroid. 2004;14:1072-1076.
121. Prat F, Chapelon JY, Arefiev A, et al. High-intensity focused ultrasound transducers suitable for endoscopy: feasibility study in rabbits. Gastrointest Endosc. 1997;46:348-351.
122. Paterson RF, Barret E, Siqueira TM Jr, et al. Laparoscopic partial kidney ablation with high intensity focused ultrasound. J Urol. 2003;169:347-351.